FOLH1 and prostate cancer: <b>Introduction:</b> [<sup>18</sup>F]-DCFPyL (Piflufolastat [<sup>18</sup>F]) is a prostate-specific membrane antigen (PSMA)-targeted position emission tomography (PET) radiotracer for detecting the biochemical recurrence (BCR) of prostate cancer (PCa).